Interventional, Randomised, Double-blind 4-way Crossover Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women

Trial Profile

Interventional, Randomised, Double-blind 4-way Crossover Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2014

At a glance

  • Drugs Vortioxetine (Primary)
  • Indications Anxiety disorders; Generalised anxiety disorder; Major depressive disorder
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 08 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top